Correlation Between Intellipharmaceutics and Cannabics Pharmaceuticals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Intellipharmaceutics and Cannabics Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Intellipharmaceutics and Cannabics Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Intellipharmaceutics International and Cannabics Pharmaceuticals, you can compare the effects of market volatilities on Intellipharmaceutics and Cannabics Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Intellipharmaceutics with a short position of Cannabics Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Intellipharmaceutics and Cannabics Pharmaceuticals.

Diversification Opportunities for Intellipharmaceutics and Cannabics Pharmaceuticals

-0.2
  Correlation Coefficient

Good diversification

The 3 months correlation between Intellipharmaceutics and Cannabics is -0.2. Overlapping area represents the amount of risk that can be diversified away by holding Intellipharmaceutics Internati and Cannabics Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cannabics Pharmaceuticals and Intellipharmaceutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Intellipharmaceutics International are associated (or correlated) with Cannabics Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cannabics Pharmaceuticals has no effect on the direction of Intellipharmaceutics i.e., Intellipharmaceutics and Cannabics Pharmaceuticals go up and down completely randomly.

Pair Corralation between Intellipharmaceutics and Cannabics Pharmaceuticals

If you would invest  1.00  in Cannabics Pharmaceuticals on October 27, 2024 and sell it today you would earn a total of  0.00  from holding Cannabics Pharmaceuticals or generate 0.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy1.67%
ValuesDaily Returns

Intellipharmaceutics Internati  vs.  Cannabics Pharmaceuticals

 Performance 
       Timeline  
Intellipharmaceutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Intellipharmaceutics International has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable forward indicators, Intellipharmaceutics is not utilizing all of its potentials. The newest stock price disturbance, may contribute to mid-run losses for the stockholders.
Cannabics Pharmaceuticals 

Risk-Adjusted Performance

4 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Cannabics Pharmaceuticals are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of fairly inconsistent fundamental drivers, Cannabics Pharmaceuticals showed solid returns over the last few months and may actually be approaching a breakup point.

Intellipharmaceutics and Cannabics Pharmaceuticals Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Intellipharmaceutics and Cannabics Pharmaceuticals

The main advantage of trading using opposite Intellipharmaceutics and Cannabics Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Intellipharmaceutics position performs unexpectedly, Cannabics Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cannabics Pharmaceuticals will offset losses from the drop in Cannabics Pharmaceuticals' long position.
The idea behind Intellipharmaceutics International and Cannabics Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .

Other Complementary Tools

Content Syndication
Quickly integrate customizable finance content to your own investment portal
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device